Compare RWT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RWT | OPK |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.9M | 1.0B |
| IPO Year | 1996 | 2011 |
| Metric | RWT | OPK |
|---|---|---|
| Price | $4.05 | $1.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $6.82 | $1.60 |
| AVG Volume (30 Days) | ★ 6.4M | 2.5M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 12.83% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $22.21 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.22 | $0.98 |
| 52 Week High | $6.97 | $1.73 |
| Indicator | RWT | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 66.07 |
| Support Level | $3.22 | $1.12 |
| Resistance Level | $4.93 | $1.73 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 63.00 | 82.69 |
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.